Loop Capital raised the firm’s price target on Stryker to $312 from $290 and keeps a Buy rating on the shares. The company’s 2023 guidance calling for organic sales growth of 7.0%-8.5% reflects a strong topline momentum, but only modest operating leverage given supply and inflationary pressure, the analyst tells investors in a research note.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SYK:
- Stryker price target raised to $314 from $283 at Barclays
- Stryker price target raised to $326 from $290 at Citi
- Stryker price target raised to $320 from $292 at Jefferies
- Zimmer Biomet upgraded to Hold from Underperform at Jefferies
- Stryker to announce financial results for its first quarter of fiscal year 2023